Cefadroxil

头孢羟氨

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefadroxil
Drug Alias Namecefadroxilo头孢羟氨苄霉素羟氨苄头孢菌素Cefadroxilum头孢羟氨苄 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsUrinary Tract InfectionsTonsillitis +[5] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1978/02/17
Country/TerritoryCanadaUnited StatesEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesSunflower Pharmaceutical Group Hubei Wudang Co LtdHarbin Pharmaceutical Group Co Ltd General Pharm FactoryHeilongjiang Nuojie Pharmaceutical Co Ltd +[4] 
Inactive CompaniesGenuine Research Center, EgyptWarner Chilcott LtdTeva Pharmaceuticals Usa Inc
Active IndicationsBacterial Infections
Inactive IndicationsAcute bacterial skin and skin structure infectionsUrinary Tract InfectionsTonsillitis +[4] 

Other Information

ATC CodeJ01DB05
Related LinksWikipediaDrugBankKEGG